NEOS
Neos Therapeutics, Inc
NEOS
NEOS
Delisted
NEOS was delisted on the 19th of March, 2021.
54 hedge funds and large institutions have $32.7M invested in Neos Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $23K
Holders
54
Holding in Top 10
1
Calls
–
Puts
$23K
Top Buyers
| 1 | +$874K | |
| 2 | +$538K | |
| 3 | +$391K | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$347K |
| 5 |
Goldman Sachs
New York
|
+$205K |
Top Sellers
| 1 | -$570K | |
| 2 | -$159K | |
| 3 | -$121K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$97.8K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$58.4K |